ROBERT MCCARRON: Open Payments
NPI 1831173087 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74,939 in 59 payments from 3 companies in 2025. Trend: 2023 $22,826 · 2024 $26,767 · 2025 $74,939
Speaker / faculty: $41,209Consulting: $25,015Travel & lodging: $7,204Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 41 | $48,743 |
| Alkermes, Inc. | 10 | $17,255 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $8,940 |
Products named: CAPLYTA, LYBALVI, REJOYN.
Industry payments across CA — which companies pay providers there.
